SIFY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now. Despite a short-term momentum fade (MACD histogram negative), SIFY’s broader trend is still bullish (SMA_5 > SMA_20 > SMA_200), options positioning is strongly call-skewed (very low put/call), and the latest quarter shows improving fundamentals (revenue up and losses narrowing). For an impatient investor who doesn’t want to wait for a perfect pullback, the current ~$14.80 level is a reasonable entry with upside toward the next resistance zone around ~$15.60–$16.22.
Trend: Uptrend/bull structure as moving averages are stacked bullish (SMA_5 > SMA_20 > SMA_200), suggesting the larger trend remains constructive. Momentum: MACD histogram is -0.0547 and negatively expanding, implying near-term momentum has weakened and price could chop/pull back before advancing. Strength: RSI_6 ~53.8 is neutral (no overbought/oversold), consistent with a tradable but not “breakout-strong” setup. Levels: Pivot ~14.593 is the key near-term line; holding above it keeps the bullish bias intact. Upside resistance at R1 ~15.601, then R2 ~16.223. Downside supports at S1 ~13.585, then S2 ~12.962. Pattern-based forward look: Similar-pattern stats imply mixed very short-term odds (some chance of a small next-day dip) but a positive skew over the next week/month (+6.3% next week; +10.88% next month in the provided projection), aligning with the broader uptrend.
Options market positioning is strongly bullish (very low put/call ratios plus a volume surge).
Trend structure remains bullish with moving averages stacked positively.
Latest reported quarter (2026/Q
shows growth and improving profitability trajectory: revenue up YoY and net loss narrowing; gross margin improved.
No negative news headlines in the last week (reduced headline risk in the immediate term).
MACD histogram is negative and worsening, signaling soft near-term momentum and potential for a dip/chop first.
Extremely high IV indicates the market expects large price swings; timing risk is higher if entering immediately.
No clear institutional/insider accumulation signal: hedge funds neutral over last quarter; insiders neutral over last month.
The company is still unprofitable (net income remains negative), which can limit sustained multiple expansion without further operating improvement.
Latest quarter: 2026/Q3. Revenue: 130,193,636.28 (+4.79% YoY), indicating steady top-line growth. Net income: -3,693,834.63 (improved +20.90% YoY; still a loss but narrowing). EPS: -0.04 (improved; provided as +100% YoY), showing per-share losses reduced. Gross margin: 23.73 (+7.33% YoY), a constructive sign for operating leverage if sustained. Overall: Moderate revenue growth plus improving margins and a narrowing loss support a bullish bias from a fundamentals trend perspective.
No analyst rating or price target change data was provided, so a recent Wall Street upgrade/downgrade trend cannot be confirmed. With the available information, the ‘pros’ case is improving quarterly trend and bullish derivatives sentiment; the ‘cons’ case is continued losses and soft near-term momentum per MACD.
